Although it has been reported that the cancer-prevention function of metformin is associated with LKB1/AMPK [7, 8], mTOR [9], p53/REDD1 [9], pEGFR and IGF-1R [10], p27 and p21 [11], the more accurate underlying molecular mechanisms still need further evaluation. This evidence concerns the gene PRKAA1 and cancer.